About Conversio Health
Conversio Health is a private company based in San Luis Obispo, California. It has reported $39,019,796 raised in three offerings on Form D since September 2013.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 27, 2024 | Feb 9, 2024amended Oct 14, 2025 | $20,273,660of $25.0M target | 1 | $20.2M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Oct 14, 2020 | Oct 28, 2020amended Mar 3, 2021 | $3,921,136of $5.0M target | 14 | $280K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 13, 2013 | Sep 24, 2013 | $14,825,000of $17.3M target | 26 | $570K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $39,019,796 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Conversio Health's Form D filed Oct 14, 2025.
RF
Richard Frank
Director
SW
Scott Waddell
Executive officer
ME
Matthew Etheridge
Director
JP
Jonathan Phillips
Director
TC
Taylor Cline
Executive officer and director
PC
Patrick Cline
Director
JH
James Hoxter
Director
DH
Dylan Herr
Executive officer
RK
Rachel Kern
Director
CW
Christopher Wooley
Executive officer
AB
Amanda Bringe
Executive officer
Earlier filings also listed Jesse Bland (director, last listed Mar 2021), Bartho van Otterdyk (vice president finance, last listed Mar 2021), Rock Morphis (director, last listed Sep 2013), Michael Holohan (executive officer, last listed Sep 2013) and Kirk Clove (chief executive officer and director, last listed Sep 2013).